Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to test whether a focused questionnaire and laboratory tests can better define risk factors associated with possible genetic porphyria. The investigators hypothesize that the genetic carrier state of acute porphyria is distinctive enough that the Genetic Carrier Profile the investigators devise through this study will be useful in identifying carriers of genetic porphyria among the large population with undiagnosed abdominal pain.


Clinical Trial Description

The porphyrias are a group of genetic diseases caused by disturbances in the formation of heme, an essential component of hemoglobin and other proteins, leading to either acute (neurologic) and/or chronic (cutaneous) symptoms. Acute porphyria is often difficult to diagnose because symptoms may not be specific and, unless the patient is in an active attack, laboratory values typically may not be useful for diagnosing porphyria. The purpose of this study is to test whether a focused questionnaire and laboratory evaluation tool can better define risk factors associated with possible genetic porphyria. The goals of this study are: - To determine the presence and number of abnormal lab tests and porphyria-like symptoms in adult family members of the first person in a family who has been diagnosed with a disease of acute porphyria, 50% of whom are expected to carry the same genetic defect of the index case. - To devise a Genetic Carrie Profile that could be used to screen people in whom the diagnosis of porphyria is being considered. - To test the Profile in patients with symptoms suggestive of HCP and/or urine tests showing some elevation of porphyrins. - To explain other possible causes of minor increases in porphyrin levels in patients with recurrent abdominal pain who have not been diagnosed with porphyria ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01568554
Study type Observational
Source University of California, San Francisco
Contact
Status Completed
Phase
Start date December 2011
Completion date December 2018

See also
  Status Clinical Trial Phase
Recruiting NCT05502133 - Identification of Acute Intermittent Porphyria Modifying Genes
Terminated NCT03547297 - INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
Completed NCT03505853 - A Study to Investigate the Interaction Between Givosiran and a 5-probe Drug Cocktail in Patients With Acute Intermittent Porphyria (AIP) Phase 1